• xxx

FULGENZI, Dr Claudia (Chair)

Dr. Claudia AM Fulgenzi is a specialist in Medical Oncology at Imperial College London, with dedicated professional interest in the field of immune-oncology and gastro-intestinal malignancies.

 

Dr. Fulgenzi graduated in medicine from the University of Rome Tor Vergata in 2017, and she subsequently  specialized in Medical Oncology at the University Campus Bio Medico of Rome, Italy. Throughout her training, Dr. Fulgenzi developed a keen interest in gastrointestinal cancers, particularly hepatic-biliary malignancies.

 

In 2021, Dr. Fulgenzi moved to London to join Imperial College as a research fellow, and she had subsequently started a PhD program focused on cancer-immunotherapy in October 2022.

 

Her contributions to the field have been recognized with prestigious awards, including the ASCO Merit Award and the Young Investigator award by the International Liver Cancer Association (ILCA) in 2022, followed by another merit award from the American Society of Clinical Oncology in 2023.

 

Concurrently, Dr. Fulgenzi, is also actively engaged in clinical practice, serving as an Honorary Consultant in Oncology at Chelsea and Westminster Hospital and as a specialty Doctor in the Early Phase Clinical Trial unit at Hammersmith Hospital. In these capacities, she conducts clinical and translational research, contributes to clinical trial design, and provides expert medical guidance to cancer patients.

UK Oncology Forum 2024

The UK Oncology Forum is only open to UK healthcare professionals. By choosing to continue to enter the UK Oncology Forum website, you are confirming that you are a UK healthcare professional.